Akebia Therapeutics's chart data is dated 2026-10-07. Recorded technical signals: MACD bullish cross. There are 0 published signal records.
Akebia Therapeutics last closed at $0.8734 (-0.58%) on 2026-10-07. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -7.9×. Its overall grade ranks 694 of 737 stocks in Healthcare.
About this company
Akebia Therapeutics last closed at $0.8734 (-0.58%) on 2026-10-07. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 694/737
Valuation grade B-
Related stocks
- OtsukaCustomer
Auryxia의 미국 판권/상업화와 관련된 핵심 파트너
- Vifor PharmaCompetitor
철결핍성 빈혈 치료제 분야에서 경쟁 구도
- FibroGenCompetitor
HIF-PH 억제제 계열 빈혈 치료제 경쟁사
About Akebia Therapeutics
- What technical signals does Akebia Therapeutics (AKBA) have?
- Akebia Therapeutics current technical signals: MACD bullish cross.
- Is Akebia Therapeutics a cup-and-handle pattern?
- No. Akebia Therapeutics has no valid Cup signal right now.
- What published figures are available for Akebia Therapeutics?
- Market cap: $231.77M. Trailing 12 months PER: -7.9×. Latest quarter PBR: 9.41×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-08 dataset
Turn what you saw on this name into a strategy
Ask Q about Akebia Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.